|
|
国际病理 2008, 28(6) 7-495 DOI:
ISSN: 0412-1961 CN: 21-1139/TG |
|
|
|
|
本期目录 |
下期目录 |
过刊浏览 |
高级检索
[打印本页]
[关闭]
|
|
| 综述 |
|
|
NPM1基因突变与急性髓细胞白血病 |
|
|
韦怡怡综述 罗军， 卢玉英审校 |
|
|
广西医科大学第一附属医院血液内科，南宁 530021 |
|
|
摘要：
NPM1(nucleophosmin,又称B23, numatrin或N038)是一种主要定位于核仁，可在核仁与胞浆之间穿梭的核磷蛋白。第12外显子突变导致NPM1胞浆异位从而发生肿瘤转化。NPM1突变与正常核型的急性髓细胞白血病、成年女性、多系受累、CD34-、 FLT3-ITD、独特的临床表现及良好的预后有关。对于NPM1+/FLT3-ITD-患者，移植与否对预后无差别。NPM1突变导致白血病发生的机制尚不清楚。 |
|
|
关键词：
核磷蛋白
急性髓细胞白血病
基因突变
|
|
|
NPM1 gene mutation and acute myeloid leukemia |
|
|
WEI Yi-yi, LUO Jun, LU Yu-ying
|
|
|
Department of Hematology, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China
|
|
|
Abstract:
NPM1 (nucleophosmin, also named as B23, numatrin or N038) is a nucleophosmin that is localized mainly in the nucleolus, continuously shuttles between the nucleus and cytoplasm .Mutations in exon 12 cause cytoplasmic NPM1 localization, and consequently contribute to tumour development.NPM1 mutations correlate with normal karyotype acute myeloid leukemia, adult female, multilineage involvement, CD34 negativity,FLT3-ITD,special clinical feature and better prognosis.For the patients with NPM1-mutated/FLT3 ITD-negative, there is no different prognosis between allogeneic SCT and non-allogeneic SCT. Now how mutated NPM1 contributes to leukemogenesis still remains to be explored. |
|
|
Keywords:
NPM1（nucleophosmin）
|
|
|
收稿日期 2008-07-31 修回日期 2008-09-20 网络版发布日期 |
|
|
DOI: |
|
|
基金项目:
|
|
|
通讯作者: 韦怡怡 |
|
|
作者简介: |
|
作者Email: |
|
|
| 参考文献： |
|
| 本刊中的类似文章 |
|
| 文章评论 |
|
|
|
| Copyright by 国际病理 |
